CRYO CELL INTERNATIONAL INC (CCEL)
About CRYO CELL INTERNATIONAL INC
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2017
- $25.4M
- Net income
- -$2.4M
- Total assets
- $61.7M
- Market cap
- $28.2M
- Gross margin
- 76.6%
- Operating margin
- 1.5%
- Net margin
- -7.7%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $31.6M
- Cost of revenue
- $7.4M
- Gross profit
- $24.2M
- Operating expenses
- $23.7M
- Operating income
- $482.4K
- Income tax
- $92.2K
- Net income
- -$2.4M
- EPS (basic)
- $-0.30
- EPS (diluted)
- $-0.30
Balance sheet
- Total assets
- $61.7M
- Current assets
- $11.8M
- Total liabilities
- $80.3M
- Current liabilities
- $19.8M
- Shareholders’ equity
- -$18.6M
Cash flow
- Operating cash flow
- $5.5M
- Investing cash flow
- -$975.3K
- Financing cash flow
- -$4.7M
- Net cash flow
- -$241.9K
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $28.2M
- EPS (diluted)
- $-0.3
- Dividend yield
- 17.34%
- Shares outstanding
- 8.1M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Cryo Cell International Inc (CCEL) Stock Price
- Reported a net loss of $2.4M in FY2017.
- Revenue grew 9% from FY2021 to FY2025.
- Gross margin of 76.6%, net margin -7.7%.
- Trading 36% below its 52-week high.
- Pays a dividend yielding about 17.34% annually.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review CRYO CELL INTERNATIONAL INC.
Write a review
News about CRYO CELL INTERNATIONAL INC
News & sentiment via Polygon.io
Cryo Cell International Inc: frequently asked questions
Is Cryo Cell International Inc an American company?
Cryo Cell International Inc is a US-based company headquartered in Oldsmar, Florida, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Cryo Cell International Inc headquartered?
Cryo Cell International Inc is headquartered in Oldsmar, Florida, United States.
Is Cryo Cell International Inc publicly traded?
Yes — Cryo Cell International Inc is a publicly traded company. Its stock trades under the ticker symbol CCEL on the NYSE.
What does Cryo Cell International Inc do?
Cryo Cell International Inc is an American Medical Devices company in the Health & Beauty sector.
